David E. Wheadon - 22 May 2025 Form 4 Insider Report for Sotera Health Co (SHC)

Role
Director
Signature
Matthew J. Klaben, Attorney-in-Fact
Issuer symbol
SHC
Transactions as of
22 May 2025
Net transactions value
$0
Form type
4
Filing time
27 May 2025, 16:46:51 UTC
Previous filing
12 Jun 2024
Next filing
16 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wheadon David E. Director C/O SOTERA HEALTH COMPANY, 9100 SOUTH HILLS SUITE 300, BROADVIEW HEIGHTS Matthew J. Klaben, Attorney-in-Fact 27 May 2025 0001789507

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SHC Common Stock, $0.01 par value per share ("Common Stock") Award $0 +19,132 +34% $0.000000 74,912 22 May 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities consist of 19,132 restricted stock units ("RSUs") that were granted on May 22, 2025, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.
F2 These securities consist of 19,132 RSUs and 55,780 shares of Common Stock.

Remarks:

The Power of Attorney for Mr. Wheadon is filed as an exhibit to the Form 3 filed with the Securities and Exchange Commission on May 28, 2021, which is hereby incorporated by reference.